Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Amar Remedies Ltd (AMAR)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532664 NSE: AMAR Household & Personal Products | Small Cap | Amar Remedies Share Price
BSE Share Price
Not Listed
Not Listed
Amar Remedies Ltd (AMAR)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532664 NSE: AMAR Household & Personal Products | Small Cap | Amar Remedies Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹16 Cr.
Current Price
₹0
52-Week Low / High
₹6 / 6
TTM EPS
₹17.4
TTM Sales
₹684 Cr.
Book Value per Share
₹99.6
P/E Ratio
0.35
Industry PE
41
Price to Book (P/B)
0.06
Price to Sales (P/S)
0.02
EV/EBITDA
3.36
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
19.16%
Return on Capital Employed (ROCE)
17.64%
Return on Assets (ROA)
7.72%
Operating Profit Margin
16.9%
Net Profit Margin
6.65%
Gross Profit Margin
11%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
16.67%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
35.71%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
16.19%
Asset Quality
Promoter Holding
24.60%
Pledged shares (%) of Promoter's holding (%)
99.66%
Reserves
₹236 Cr.
Equity
₹26.2 Cr.
Face Value
₹10
All Time Low / High
₹5.48 / 171.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Jun'03 | Jun'04 | Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 16% | 26.6% | 35.4% | 18.7% | 20.2% | 20.4% | 21.9% | 18.9% | 17.7% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 82.2 | 107 | 167 | 202 | 298 | 369 | 472 | 578 | 674 | 492 |
| Sales YoY Gr. | - | NA | 29.9% | 56.5% | 20.9% | 47.6% | 23.8% | 28% | 22.4% | 16.7% | - |
| Adj EPS ⓘ | 0 | 3.3 | 6.2 | 8 | 6.5 | 8.3 | 10.2 | 12.4 | 14.5 | 19.2 | -16.2 |
| YoY Gr. | - | NA | 90.5% | 29.4% | -18.7% | 27.8% | 22.6% | 21.2% | 17.3% | 32.6% | - |
| BVPS (₹) ⓘ | 0 | 16.2 | 22.4 | 31.9 | 38.6 | 47.1 | 56.3 | 67.6 | 81.2 | 98.7 | 83.2 |
| Adj Net Profit ⓘ | 0 | 3.6 | 6.9 | 21 | 17.1 | 21.8 | 26.7 | 32.3 | 37.9 | 50.3 | -42 |
| Cash Flow from Ops. ⓘ | 0 | 0 | -1.4 | -9.1 | 15.4 | 2.3 | 2.9 | -12.2 | -0.1 | -21.1 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | -10.9 | -3.2 | 3.5 | 24.3 | 30 | -10.2 | -1777.2 | -18 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 27.3% | 22.2% | 16.7% | ||||
| Adj EPS ⓘ | NA | 24.2% | 23.5% | 32.6% | ||||
| BVPSⓘ | NA | 20.7% | 20.6% | 21.5% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Jun'03 | Jun'04 | Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 18 | 29.4 | 35.9 | 17.4 | 18.5 | 19 | 19.4 | 19.1 | 21.1 | -17.8 |
| Op. Profit Mgn % ⓘ | 0 | 6.6 | 9.4 | 16.6 | 13.1 | 11.9 | 12.9 | 14.5 | 14.2 | 17.1 | 7.2 |
| Net Profit Mgn % ⓘ | 0 | 4.4 | 6.5 | 12.5 | 8.4 | 7.3 | 7.2 | 6.8 | 6.6 | 7.5 | -8.6 |
| Debt to Equity ⓘ | 0 | 0.7 | 0.6 | 0.4 | 0.5 | 0.5 | 0.6 | 0.7 | 1.2 | 1.5 | - |
| Working Cap Days ⓘ | 0 | 0 | 117 | 125 | 154 | 131 | 147 | 161 | 182 | 228 | 63 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 110 | 116 | 138 | 119 | 131 | 140 | 153 | 182 | 17 |
Valuation of Amar Remedies - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 78.00 | 88.49 | 88.74 | 91.19 | 95.74 | 99.59 | 98.98 | 98.98 | 99.67 | 99.66 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Jun'09 | Jun'10 | Jun'11 | Jun'12 |
|---|---|---|---|---|
| Sales | 369.16 | 490.79 | 597 | 684.37 |
| Operating Expenses ⓘ + | 321.69 | 422.26 | 513.63 | 571.23 |
| Operating Profit ⓘ | 47.47 | 68.54 | 83.37 | 113.14 |
| Operating Profit Margin (%) | 12.9% | 14.0% | 14.0% | 16.5% |
| Other Income ⓘ + | 1.88 | 1.13 | 1.04 | 2.08 |
| Interest ⓘ | 12.44 | 20.78 | 27.43 | 39.76 |
| Depreciation ⓘ | 7.12 | 10.29 | 11.04 | 12.82 |
| Profit Before Tax ⓘ | 29.80 | 38.60 | 45.93 | 57.60 |
| Tax ⓘ | 3.17 | 5.68 | 6.79 | 12.11 |
| Profit After Tax | 26.63 | 32.92 | 39.15 | 45.49 |
| PAT Margin (%) | 7.2% | 6.7% | 6.6% | 6.7% |
| Adjusted EPS (₹) | 10.2 | 12.6 | 15.0 | 17.4 |
| Dividend Payout Ratio (%) | 9.80% | 8% | 6.70% | 0% |
| PARTICULARS | Jun'09 | Jun'10 | Jun'11 | Jun'12 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 151.84 | 181.61 | 217.66 | 263.47 | |||||||
| Debt + | 88.28 | 124.10 | 249.18 | 365.42 | |||||||
| Minority Interest | 0 | 0 | 0 | 0 | |||||||
| Trade Payables | 8.69 | 12.75 | 13.85 | 16.98 | |||||||
| Others Liabilities ⓘ | 39.09 | 47.69 | 12.12 | 40.35 | |||||||
| Total Liabilities ⓘ | 287.89 | 366.14 | 492.81 | 686.22 | |||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 108.20 | 115.39 | 123.95 | 164.70 | |||||||
| CWIP ⓘ | 0 | 0.82 | 14.22 | 4.21 | |||||||
| Investments ⓘ | 0.13 | 0 | 0 | 0 | |||||||
| Inventories | 80.27 | 113.80 | 152.50 | 233.04 | |||||||
| Trade Receivables | 82.32 | 111.06 | 142.54 | 187.78 | |||||||
| Cash Equivalents | 0.70 | 3.79 | 12.02 | 8.77 | |||||||
| Others Assets ⓘ | 16.27 | 21.28 | 47.58 | 87.72 | |||||||
| Total Assets ⓘ | 287.89 | 366.14 | 492.81 | 686.22 | |||||||
| PARTICULARS | Jun'09 | Jun'10 | Jun'11 | Jun'12 |
|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 2.50 | -11.03 | -1.83 | -31.25 |
| Cash Flow From Investing Activity ⓘ + | -31.38 | -18.64 | -47.08 | -48.85 |
| Cash Flow From Financing Activity ⓘ + | 29.48 | 32.76 | 57.13 | 76.85 |
| Net Cash Flow ⓘ | 0.60 | 3.09 | 8.22 | -3.25 |
| PARTICULARS | Jun'09 | Jun'10 | Jun'11 | Jun'12 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 18.09 | 20.27 | 19.98 | 19.16 | ||||||
| ROCE (%) | 17.93 | 22.11 | 19.16 | 17.64 | ||||||
| Asset Turnover Ratio | 1.28 | 1.5 | 1.4 | 1.17 | ||||||
| PAT to CFO Conversion(x) | 0.09 | -0.34 | -0.05 | -0.69 | ||||||
| Working Capital Days | ||||||||||
| Receivable Days | 81.40 | 71.90 | 77.10 | 87.50 | ||||||
| Inventory Days | 79.40 | 72.20 | 81 | 102.10 | ||||||
| Payable Days | 14.80 | 13.90 | 10.30 | 10.80 | ||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Amar Remedies Ltd FAQs
The current trading price of Amar Remedies on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Amar Remedies stood at ₹15.88 Cr
The latest P/E ratio of Amar Remedies as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Amar Remedies as of 31-Dec-1969 is 0.07.
The 52-week high of Amar Remedies is ₹6.34 and the 52-week low is ₹5.74.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amar Remedies is ₹492 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Amar Remedies Ltd
Amar Remedies, incorporated 1984, is engaged in the business of manufacturing a range of FMCG products. The company was incorporated as Swami Aushadalaya to foray into ayurvedic medicinal research and development. Later in 1995 the name of the company was changed to Amar Remedies.
The company established its first manufacturing facility in Surat, Gujarat. At that time when major toothpaste brands used gelatine as an ingredient, making their toothpastes non-vegetarian. Amar became first to launch a breakthrough product, which was a gelatine-free formula. In 1991, the company launched a ‘Vegetarian’ toothpaste in Gujarat.
Much later in 1998 the company widened its product portfolio and introduced Amar Strong, Amar Regular and Amar White Toothpaste.
In 2001, the company commenced a new manufacturing facility at Daman. This led to increase in capacity of manufacturing facility and developing more varieties of toothpaste.
Today ARL manufactures 25 ayurvedic and herbal products for local and export markets. Amar's products are exported to over 20 countries like USA, Canada, Italy, France, UK, Nigeria, Ghana, Sudan, Tanzania, Dubai and Panama, among others.
Headquartered in Mumbai, the company’s manufacturing facilities are located at Daman, Dehradun and Surat.
The company has a product portfolio that includes toothpastes, toothbrushes, petroleum jelly, talc, soaps, shampoo, lotions and creams. The company markets its products under brand name ‘Amar’.
The company has received ISO 9001:2000 certification for its quality management. The company has also received International Gold Star for Quality Award at the International Star Quality Convention held at Paris in 2007. The company is recognised as ‘One Star Export House’ by Government of India and ministry of commerce and industry.
Future Strategy
Amar Remedies plans to invest Rs 25 crore to open 9 exclusive outlets of its newly-launched brand ‘The Nature’s Co’ in the next 18 months. The company is intending to open these outlets in metros as well as Tier I and II cities including Mumbai, Bangalore, Hyderabad, Pune, Surat and Chandigarh.
You have 45 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
